On Friday, Charles River Laboratories International Inc. (NYSE: CRL) opened lower -0.01% from the last session, before settling in for the closing price of $197.78. Price fluctuations for CRL have ranged from $161.65 to $275.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 12.89%. Company’s average yearly earnings per share was noted -6.23% at the time writing. With a float of $51.04 million, this company’s outstanding shares have now reached $51.34 million.
The extent of productivity of a business whose workforce counts for 21800 workers is very important to gauge. In terms of profitability, gross margin is 33.88%, operating margin of 14.64%, and the pretax margin is 13.25%.
Charles River Laboratories International Inc. (CRL) Insider Updates
A key investor’s attitude towards the stock of the Diagnostics & Research industry is another important factor to consider. The insider ownership of Charles River Laboratories International Inc. is 1.14%, while institutional ownership is 103.19%. The most recent insider transaction that took place on Aug 08 ’24, was worth 354,861. In this transaction EVP, Corp Strategy & Develop of this company sold 1,780 shares at a rate of $199.36, taking the stock ownership to the 22,521 shares. Before that another transaction happened on Aug 08 ’24, when Company’s Officer proposed sale 1,780 for $196.63, making the entire transaction worth $350,000.
Charles River Laboratories International Inc. (CRL) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted 2.72 earnings per share (EPS) for the quarter, besting the agreed prediction (set at 2.37) by 0.35. Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.51 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -6.23% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 3.24% during the next five years compared to 14.84% growth over the previous five years of trading.
Charles River Laboratories International Inc. (NYSE: CRL) Trading Performance Indicators
Check out the current performance indicators for Charles River Laboratories International Inc. (CRL). In the past quarter, the stock posted a quick ratio of 1.21. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.50. Likewise, its price to free cash flow for the trailing twelve months is 20.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 8.46, a number that is poised to hit 2.42 in the next quarter and is forecasted to reach 10.45 in one year’s time.
Technical Analysis of Charles River Laboratories International Inc. (CRL)
The latest stats from [Charles River Laboratories International Inc., CRL] show that its last 5-days average volume of 0.58 million was inferior to 0.6 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 83.00%. Additionally, its Average True Range was 5.32.
During the past 100 days, Charles River Laboratories International Inc.’s (CRL) raw stochastic average was set at 17.87%, which indicates a significant decrease from 81.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 16.59% in the past 14 days, which was lower than the 36.20% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $197.27, while its 200-day Moving Average is $221.89. Now, the first resistance to watch is $200.27. This is followed by the second major resistance level at $202.78. The third major resistance level sits at $205.03. If the price goes on to break the first support level at $195.51, it is likely to go to the next support level at $193.26. Assuming the price breaks the second support level, the third support level stands at $190.75.
Charles River Laboratories International Inc. (NYSE: CRL) Key Stats
There are currently 51,510K shares outstanding in the company with a market cap of 10.21 billion. Presently, the company’s annual sales total 4,129 M according to its annual income of 474,620 K. Last quarter, the company’s sales amounted to 1,026 M and its income totaled 94,080 K.
